Leukapheresis is a procedure which is used to treat lymphocytic leukemia patients with very high white blood cell (WBC) counts. Leukemia starts in early form of blood cells usually leucocytes (WBC) which helps to fight against infections caused by foreign particles. Leukapheresis devices are used during Leukapheresis procedures. These devices are classified into various types such as Apheresis Devices, Leukopheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables.
Rise in incidences of leukemia and number of blood donations are considered as driving factors which are expected to boost the global leukopheresis devices market growth. For instance, as per the IARC (International Agency for Research on Cancer) in 2018, aproximately 437,033 leukemia cases were registed and 309,006 deaths are occurred because of leukemia, across the world. The need for blood and blood products is rising every year in various countries- especially in low and middle income countries. Transfusion of blood and their products help patients suffering from life threatening conditions to live longer and maintain quality of life and supports surgical and medical procedures. For instance, as per the information of American National Red Cross 2020, around 21 million blood components are transfused every year in United State. North America is expected to witness for largest share in leukapheresis devices market due to increase in prevalence and incidences of leukemia in North America. For instance, as per the Leukemia and Lymphoma Society and American cancer society, from year 2011 to 2015 in the United State leukemia was the sixth most common cause of death in both women and men.
However, high cost of apheresis procedures and devices are major challenging factors which are expected to hinder the global leukapheresis devices market growth. For instance, in Unite State cost of apheresis procedure is around USD 2500 per treatment which is very high. Further, in India apheresis machine prices is approximately USD 23,459 and there is an apheresis kit which is required for separating components costing with approximate price USD 134. It is very costly for low-income people to afford.
Global Leukapheresis Devices Market is segmented into type such as Apheresis Devices, Leukoreduction Filters, Leukopheresis Columns & Cell Separators, and Leukapheresis Disposables, by application such as Therapeutic Application and Research Application. Further, market is segmented into end users such as Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, and Blood Component Providers and Blood Centers.
Also, Global Leukapheresis Devices Market is segmented into is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Asahi Kasei Medical Co. Ltd, Terumo BCT Inc, Haemonetics Corporation, Fresenius SE & Co. KGaA, STEMCELL Technologies Inc, Grifols, S.A, BioIVT,and Key Biologics, LLC.
By Type
Apheresis Devices Leukoreduction Filters Leukopheresis Columns & Cell Separators Leukapheresis Disposables
By Application
Therapeutic Application Research Application
By End User
Hospitals Academic and Research Institutes Pharmaceutical and Biotechnological Companies Blood Component Providers and Blood Centers
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Leukapheresis Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Leukapheresis Devices Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Leukapheresis Devices Market Share Analysis, By Type
5.3 Global Leukapheresis Devices Market Size and Forecast, By Type
5.3.1 Apheresis Devices
5.3.2. Leukoreduction Filters
5.3.3 Leukopheresis Columns & Cell Separators
5.3.4 Leukapheresis Disposables
6 Global Leukapheresis Devices Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Leukapheresis Devices Market Share Analysis, By Application
6.3 Global Leukapheresis Devices Market Size and Forecast, By Application
6.3.1 Therapeutic Application
6.3.2 Research Application
7 Global Leukapheresis Devices Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Leukapheresis Devices Market Share Analysis, By End User
7.3 Global Leukapheresis Devices Market Size and Forecast, By End User
7.3. 1 Hospital
7.3.2. Academic and Research Institutes
7.3.3. Pharmaceutical and Biotechnological Companies
7.3.4. Blood Component Providers and Blood Centers
8Global Leukapheresis Devices Market, By Region
8.1 Global Leukapheresis Devices Market Share Analysis, By Region
8.2 Global Leukapheresis Devices Market Share Analysis, By Region
8.3 Global Leukapheresis Devices Market Size and Forecast, By Region
9 North America Leukapheresis Devices Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Leukapheresis Devices Market Share Analysis, By Type
9.3 North America Leukapheresis Devices Market Size and Forecast, By Application
9.4 North America Leukapheresis Devices Market Size and Forecast, By End User
9.5 North America Leukapheresis Devices Market Size and Forecast, By Country
9.5.1 U.S
. 9.5.2 Canada
9.5.3 Mexico
10EuropeLeukapheresis Devices Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Leukapheresis Devices Market Share Analysis, By Type
10.3 Europe Leukapheresis Devices Market Size and Forecast, By Application
10.4 Europe Leukapheresis Devices Market Size and Forecast, By End User
10.5 Europe Leukapheresis Devices Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Leukapheresis Devices Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Leukapheresis Devices Market Share Analysis, By Type
11.3 Asia Pacific Leukapheresis Devices Market Size and Forecast, By Application
11.4 Asia Pacific Leukapheresis Devices Market Size and Forecast, By End User
11.5 Asia Pacific Leukapheresis Devices Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Leukapheresis Devices Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Leukapheresis Devices Market Share Analysis, By Type
12.3 Latin America Leukapheresis Devices Market Size and Forecast, By Application
12.4 Latin America Leukapheresis Devices Market Size and Forecast, By End User
12.5 Latin America Leukapheresis Devices Market Size and Forecast, Country
13Middle East Leukapheresis Devices Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Leukapheresis Devices Market Share Analysis, By Type
13.3 Middle East Leukapheresis Devices Market Size and Forecast, By Application
13.4 Middle East Leukapheresis Devices Market Size and Forecast, By End User
13.5 Middle East Leukapheresis Devices Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Asahi Kasei Medical Co. Ltd
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Terumo BCT Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Haemonetics Corporation
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Fresenius SE & Co. KGaA
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 STEMCELL Technologies Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Grifols, S.A
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 BioIVT
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Biologics, LLC
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
